Podnos Yale

Officer at STLN

Sold, on record
$277k
Dollars the filings state
Form 4 sales
2
Latest Jul 14, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • STLNStarling Oncology, Inc.Officer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 144 notice STLNNotice
    Jun 8, 2026 2026

    Filed to sell 23,451 shares ($114k)

    Podnos Yale, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale STLNRoutine
    Jun 8, 2026 same day

    Sold 23,451 shares at $5.38 ($126k)

    Podnos Yale, Chief Medical Officer

    10b5-1 planSold 8.3% of holdings ($1.5M position)259,527 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice STLNNotice
    Jul 14, 2026 +36 days

    Filed to sell 23,452 shares ($147k)

    Podnos Yale, Officer

    10b5-1 planFiling

  4. 4 Form 4 sale STLNRoutine
    Jul 14, 2026 same day

    Sold 23,452 shares at $6.41 ($150k)

    Podnos Yale, Chief Medical Officer

    10b5-1 planSold 8.3% of holdings ($1.8M position)259,527 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Podnos Yale
Source
Jul 14, 2026Jul 16, 2026STLNChief Medical OfficerForm 4 sale23,452$150k8.3%RoutineSEC
Jul 14, 2026Jul 14, 2026STLNOfficerForm 144 notice23,452$147kNoticeSEC
Jun 8, 2026Jun 9, 2026STLNChief Medical OfficerForm 4 sale23,451$126k8.3%RoutineSEC
Jun 8, 2026Jun 8, 2026STLNOfficerForm 144 notice23,451$114kNoticeSEC